Prostate Cancer - Results from #23180

Quality improvements in prostate radiotherapy: Outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial - Abstract May 17, 2013

Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy - Abstract May 17, 2013

Selenium and prostate cancer prevention: Insights from the Selenium and Vitamin E Cancer Prevention Trial (SELECT) - Abstract May 17, 2013

Radical radiotherapy in high-risk prostate cancer patients with high or ultra-high initial PSA levels: A single institution analysis - Abstract May 17, 2013

Improving risk stratification in patients with prostate cancer managed by active surveillance: A nomogram predicting the risk of biopsy progression - Abstract May 17, 2013

Contrast-enhanced transrectal ultrasonography: Measurement of prostate cancer tumor size and correlation with radical prostatectomy specimens - Abstract May 16, 2013

Symptom self-management strategies in patients with non-metastatic prostate cancer - Abstract May 16, 2013

The prostate cancer patient had higher C-reactive protein than BPH patient - Abstract May 16, 2013

Dietary fat, fatty acids, and risk of prostate cancer in the NIH-AARP diet and health study - Abstract May 16, 2013

Metabolomic imaging of prostate cancer with magnetic resonance spectroscopy and mass spectrometry - Abstract May 16, 2013

Can Western based online prostate cancer risk calculators be used to predict prostate cancer after prostate biopsy for the Korean population? - Abstract May 16, 2013

Intermittent versus continuous androgen deprivation in prostate cancer - Abstract May 16, 2013

Fruit and vegetable intake and prostate cancer risk: A meta-analysis - Abstract May 16, 2013

Favourable long-term outcomes with brachytherapy-based regimens in men ≤ 60 years with clinically localized prostate cancer - Abstract May 16, 2013

Outcomes of transperineal template-guided prostate biopsy in 409 patients - Abstract May 16, 2013

FDA approves new drug for advanced prostate cancer May 15, 2013

AUA 2013 - Poster: Optimal timing for treatment of metastatic castration-resistant prostate cancer (mCRPC): Sequencing and identifying parameters of early progression with sipuleucel-T May 15, 2013

AUA 2013 - Poster: Treatment practice patterns in metastatic castration-resistant prostate cancer (mCRPC) patients prior to receiving sipuleucel-T: Data from PROCEED May 15, 2013

AUA 2013 - Poster: Safety and changes in laboratory parameters associated with sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC): Phase 2 ProACT study May 14, 2013

AUA 2013 - Session Highlights: The impact of seminal vesicle invasion in patients with positive lymph node involvement at the time of radical prostatectomy May 14, 2013

Page 1160 of 1435